Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Accumulated Expenses (2016 - 2026)

Conmed filings provide 17 years of Other Accumulated Expenses readings, the most recent being $125.7 million for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses fell 2.56% to $125.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $125.7 million, a 2.56% decrease, with the full-year FY2025 number at $138.5 million, up 26.18% from a year prior.
  • Other Accumulated Expenses hit $125.7 million in Q1 2026 for Conmed, down from $138.5 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $163.5 million in Q3 2023 to a low of $62.5 million in Q1 2022.
  • Median Other Accumulated Expenses over the past 5 years was $125.1 million (2025), compared with a mean of $119.4 million.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 104.31% in 2023 and later fell 29.29% in 2024.
  • Conmed's Other Accumulated Expenses stood at $98.7 million in 2022, then skyrocketed by 53.76% to $151.7 million in 2023, then fell by 27.63% to $109.8 million in 2024, then increased by 26.18% to $138.5 million in 2025, then decreased by 9.27% to $125.7 million in 2026.
  • The last three reported values for Other Accumulated Expenses were $125.7 million (Q1 2026), $138.5 million (Q4 2025), and $130.7 million (Q3 2025) per Business Quant data.